Update on the genetics and genomics of PBC

Journal of Autoimmunity

Volumn 35, Issue 3, 2010, Pages 181-187

  Juran, Brian D ^a   Lazaridis, Konstantinos N ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; KERATIN; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22; PROGRAMMED DEATH 1 LIGAND 1; TUMOR NECROSIS FACTOR; VITAMIN D RECEPTOR;

ARTICLE; AUTOIMMUNITY; DISEASE PREDISPOSITION; GENETIC ASSOCIATION; GENETIC EPISTASIS; GENETIC VARIABILITY; GENOMICS; HUMAN; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; X CHROMOSOME;

ADULT; CHILD; CHROMOSOMES, HUMAN, X; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOMICS; HUMANS; INTERLEUKIN-12; LIVER CIRRHOSIS, BILIARY; POLYMORPHISM, GENETIC; RISK FACTORS; SIGNAL TRANSDUCTION;

EID: 77957760331     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2010.06.005     Document Type: Article

References (63)

1. Kaplan M.M., Gershwin M.E. Primary biliary cirrhosis. N Engl J Med 2005, 353:1261-1273.
2. Gershwin M.E., Rowley M., Davis P.A., Leung P., Coppel R., Mackay I.R. Molecular biology of the 2-oxo-acid dehydrogenase complexes and anti-mitochondrial antibodies. Prog Liver Dis 1992, 10:47-61.
3. Kisand K.E., Metskula K., Kisand K.V., Kivik T., Gershwin M.E., Uibo R. The follow-up of asymptomatic persons with antibodies to pyruvate dehydrogenase in adult population samples. J Gastroenterol 2001, 36:248-254.
4. Lleo A., Selmi C., Invernizzi P., Podda M., Coppel R.L., Mackay I.R., et al. Apotopes and the biliary specificity of primary biliary cirrhosis. Hepatology 2009, 49:871-879.
5. Lander E.S. The new genomics: global views of biology. Science 1996, 274:536-539.
6. Pritchard J.K. Are rare variants responsible for susceptibility to complex diseases?. Am J Hum Genet 2001, 69:124-137.
7. Peng B., Kimmel M. Simulations provide support for the common disease-common variant hypothesis. Genetics 2007, 175:763-776.
8. Selmi C., Mayo M.J., Bach N., Ishibashi H., Invernizzi P., Gish R.G., et al. Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environment. Gastroenterology 2004, 127:485-492.
9. Jones D.E., Donaldson P.T. Genetic factors in the pathogenesis of primary biliary cirrhosis. Clin Liver Dis 2003, 7:841-864.
10. Juran B.D., Lazaridis K.N. Genetics and genomics of primary biliary cirrhosis. Clin Liver Dis 2008, 12:349-365. [ix].
11. Jones D.E.J., Watt F.E., Metcalf J.V., Bassendine M.F., James O.F.W. Familial primary biliary cirrhosis reassessed: a geographically-based population study. J Hepatol 1999, 30:402-407.
12. Gershwin M.E., Selmi C., Worman H.J., Gold E.B., Watnik M., Utts J., et al. Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients. Hepatology 2005, 42:1194-1202.
13. Lazaridis K.N., Juran B.D., Boe G.M., Slusser J.P., de Andrade M., Homburger H.A., et al. Increased prevalence of antimitochondrial antibodies in first-degree relatives of patients with primary biliary cirrhosis. Hepatology 2007, 46:785-792.
14. Gregersen P.K., Behrens T.W. Genetics of autoimmune diseases-disorders of immune homeostasis. Nat Rev Genet 2006, 7:917-928.
15. Hirschfield G.M., Liu X., Xu C., Lu Y., Xie G., Lu Y., et al. Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants. N Engl J Med 2009, 360:2544-2555.
16. Begovich A.B., Klitz W., Moonsamy P.V., Van de Water J., Peltz G., Gershwin M.E. Genes within the HLA class II region confer both predisposition and resistance to primary biliary cirrhosis. Tissue Antigens 1994, 43:71-77.
17. Donaldson P.T., Baragiotta A., Heneghan M.A., Floreani A., Venturi C., Underhill J.A., et al. HLA class II alleles, genotypes, haplotypes, and amino acids in primary biliary cirrhosis: a large-scale study. Hepatology 2006, 44:667-674.
18. Mullarkey M.E., Stevens A.M., McDonnell W.M., Loubiere L.S., Brackensick J.A., Pang J.M., et al. Human leukocyte antigen class II alleles in Caucasian women with primary biliary cirrhosis. Tissue Antigens 2005, 65:199-205.
19. Onishi S., Sakamaki T., Maeda T., Iwamura S., Tomita A., Saibara T., et al. DNA typing of HLA class II genes; DRB1*0803 increases the susceptibility of Japanese to primary biliary cirrhosis. J Hepatol 1994, 21:1053-1060.
20. Invernizzi P., Selmi C., Poli F., Frison S., Floreani A., Alvaro D., et al. Human leukocyte antigen polymorphisms in Italian primary biliary cirrhosis: a multicenter study of 664 patients and 1992 healthy controls. Hepatology 2008, 48:1906-1912.
21. Invernizzi P., Battezzati P.M., Crosignani A., Perego F., Poli F., Morabito A., et al. Peculiar HLA polymorphisms in Italian patients with primary biliary cirrhosis. J Hepatol 2003, 38:401-406.
22. Wilson A.G., Symons J.A., McDowell T.L., McDevitt H.O., Duff G.W. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA 1997, 94:3195-3199.
23. Tanaka A., Quaranta S., Mattalia A., Coppel R., Rosina F., Manns M., et al. The tumor necrosis factor-a promoter correlates with progression of primary biliary cirrhosis. J Hepatol 1999, 30:826-829.
24. Gordon M.A., Oppenheim E., Camp N.J., di Giovine F.S., Duff G.W., Gleeson D. Primary biliary cirrhosis shows association with genetic polymorphism of tumour necrosis factor alpha promoter region. J Hepatol 1999, 31:242-247.
25. Fan L.Y., Zhong R.Q., Tu X.Q., Pfeiffer T., Feltens R., Zhu Y., et al. Genetic association of tumor necrosis factor (TNF)-alpha polymorphisms with primary biliary cirrhosis and autoimmune liver diseases in a Chinese population. Zhonghua Gan Zang Bing Za Zhi 2004, 12:160-162.
26. Niro G.A., Poli F., Andriulli A., Bianchi I., Bernuzzi F., Caliari L., et al. TNF-alpha polymorphisms in primary biliary cirrhosis: a northern and southern Italian experience. Ann NY Acad Sci 2009, 1173:557-563.
27. Juran B.D., Atkinson E.J., Schlicht E.M., Lazaridis K.N. Examination of TNF promoter polymorphisms in PBC. Hepatology 2008, 48:597A.
28. Jones D.E.J., Watt F.E., Grove J., Newton J.L., Daly A.K., Gregory W.L., et al. Tumour necrosis factor-a promoter polymorphisms in primary biliary cirrhosis. J Hepatol 1999, 30:232-236.
29. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 2003, 3:133-146.
30. Aggarwal S., Ghilardi N., Xie M.H., de Sauvage F.J., Gurney A.L. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J Biol Chem 2003, 278:1910-1914.
31. Rong G., Zhou Y., Xiong Y., Zhou L., Geng H., Jiang T., et al. Imbalance between T helper type 17 and T regulatory cells in patients with primary biliary cirrhosis: the serum cytokine profile and peripheral cell population. Clin Exp Immunol 2009, 156:217-225.
32. Lan R.Y., Salunga T.L., Tsuneyama K., Lian Z.X., Yang G.X., Hsu W., et al. Hepatic IL-17 responses in human and murine primary biliary cirrhosis. J Autoimmun 2009, 32:43-51.
33. Yoshida K., Yang G.X., Zhang W., Tsuda M., Tsuneyama K., Moritoki Y., et al. Deletion of interleukin-12p40 suppresses autoimmune cholangitis in dominant negative transforming growth factor beta receptor type II mice. Hepatology 2009, 50:1494-1500.
34. Brahmachari S., Pahan K. Suppression of regulatory T cells by IL-12p40 homodimer via nitric oxide. J Immunol 2009, 183:2045-2058.
35. Mueller D.L. Mechanisms maintaining peripheral tolerance. Nat Immunol 2010, 11:21-27.
36. Agarwal K., Jones D.E., Daly A.K., James O.F., Vaidya B., Pearce S., et al. CTLA-4 gene polymorphism confers susceptibility to primary biliary cirrhosis. J Hepatol 2000, 32:538-541.
37. Poupon R., Ping C., Chretien Y., Corpechot C., Chazouilleres O., Simon T., et al. Genetic factors of susceptibility and of severity in primary biliary cirrhosis. J Hepatol 2008, 49:1038-1045.
38. Juran B.D., Atkinson E.J., Schlicht E.M., Fridley B.L., Petersen G.M., Lazaridis K.N. Interacting alleles of the coinhibitory immunoreceptor genes cytotoxic T-lymphocyte antigen 4 and programmed cell-death 1 influence risk and features of primary biliary cirrhosis. Hepatology 2008, 47:563-570.
39. Bittencourt P.L., Palacios S.A., Farias A.Q., Abrantes-Lemos C.P., Cancado E.L., Carrilho F.J., et al. Analysis of major histocompatibility complex and CTLA-4 alleles in Brazilian patients with primary biliary cirrhosis. J Gastroenterol Hepatol 2003, 18:1061-1066.
40. Donaldson P., Veeramani S., Baragiotta A., Floreani A., Venturi C., Pearce S., et al. Cytotoxic T-lymphocyte-associated antigen-4 single nucleotide polymorphisms and haplotypes in primary biliary cirrhosis. Clin Gastroenterol Hepatol 2007, 5:755-760.
41. Oertelt S., Kenny T.P., Selmi C., Invernizzi P., Podda M., Gershwin M.E. SNP analysis of genes implicated in T cell proliferation in primary biliary cirrhosis. Clin Dev Immunol 2005, 12:259-263.
42. Juran B.D., Atkinson E.J., Schlicht E.M., Fridley B.L., Lazaridis K.N. Primary biliary cirrhosis is associated with a genetic variant in the 3' flanking region of the CTLA4 gene. Gastroenterology 2008, 135:1200-1206.
43. Walker E.J., Hirschfield G.M., Xu C., Lu Y., Liu X., Lu Y., et al. CTLA4/ICOS gene variants and haplotypes are associated with rheumatoid arthritis and primary biliary cirrhosis in the Canadian population. Arthritis Rheum 2009, 60:931-937.
44. Qu H.Q., Bradfield J.P., Grant S.F., Hakonarson H., Polychronakos C. Remapping the type I diabetes association of the CTLA4 locus. Genes Immun 2009, 10(Suppl. 1):S27-S32.
45. Rieck M., Arechiga A., Onengut-Gumuscu S., Greenbaum C., Concannon P., Buckner J.H. Genetic variation in PTPN22 corresponds to altered function of T and B lymphocytes. J Immunol 2007, 179:4704-4710.
46. Milkiewicz P., Pache I., Buwaneswaran H., Liu X., Coltescu C., Heathcote E.J., et al. The PTPN22 1858T variant is not associated with primary biliary cirrhosis. Tissue Antigens 2006, 67:434-437.
47. Parry R.V., Chemnitz J.M., Frauwirth K.A., Lanfranco A.R., Braunstein I., Kobayashi S.V., et al. CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms. Mol Cell Biol 2005, 25:9543-9553.
48. Mataki N., Kikuchi K., Kawai T., Higashiyama M., Okada Y., Kurihara C., et al. Expression of PD-1, PD-L1, and PD-L2 in the liver in autoimmune liver diseases. Am J Gastroenterol 2007, 102:302-312.
49. Prokunina L., Castillejo-Lopez C., Oberg F., Gunnarsson I., Berg L., Magnusson V., et al. A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans. Nat Genet 2002, 32:666-669.
50. Zhong B., Strnad P., Selmi C., Invernizzi P., Tao G.Z., Caleffi A., et al. Keratin variants are overrepresented in primary biliary cirrhosis and associate with disease severity. Hepatology 2009, 50:546-554.
51. Tanaka A., Nezu S., Uegaki S., Kikuchi K., Shibuya A., Miyakawa H., et al. Vitamin D receptor polymorphisms are associated with increased susceptibility to primary biliary cirrhosis in Japanese and Italian populations. J Hepatol 2009, 50:1202-1209.
52. Fan L., Tu X., Zhu Y., Zhou L., Pfeiffer T., Feltens R., et al. Genetic association of vitamin D receptor polymorphisms with autoimmune hepatitis and primary biliary cirrhosis in the Chinese. J Gastroenterol Hepatol 2005, 20:249-255.
53. Vogel A., Strassburg C.P., Manns M.P. Genetic association of vitamin D receptor polymorphisms with primary biliary cirrhosis and autoimmune hepatitis. Hepatology 2002, 35:126-131.
54. Juran B.D., Atkinson E.J., Larson J.J., Schlicht E.M., Lazaridis K.N. Common genetic variation and haplotypes of the anion exchanger SLC4A2 in primary biliary cirrhosis. Am J Gastroenterol 2009, 104:1406-1411.
55. Prieto J., Qian C., Garcia N., Diez J., Medina J.F. Abnormal expression of anion exchanger genes in primary biliary cirrhosis. Gastroenterology 1993, 105:572-578.
56. Salas J.T., Banales J.M., Sarvide S., Recalde S., Ferrer A., Uriarte I., et al. Ae2a, b-deficient mice develop antimitochondrial antibodies and other features resembling primary biliary cirrhosis. Gastroenterology 2008, 134:1482-1493.
57. Kimura Y., Selmi C., Leung P.S., Mao T.K., Schauer J., Watnik M., et al. Genetic polymorphisms influencing xenobiotic metabolism and transport in patients with primary biliary cirrhosis. Hepatology 2005, 41:55-63.
58. Schoniger-Hekele M., Muller C., Ackermann J., Drach J., Wrba F., Penner E., et al. Lack of evidence for involvement of fetal microchimerism in pathogenesis of primary biliary cirrhosis. Dig Dis Sci 2002, 47:1909-1914.
59. Invernizzi P., Miozzo M., Battezzati P.M., Bianchi I., Grati F.R., Simoni G., et al. Frequency of monosomy X in women with primary biliary cirrhosis. Lancet 2004, 363:533-535.
60. Miozzo M., Selmi C., Gentilin B., Grati F.R., Sirchia S., Oertelt S., et al. Preferential X chromosome loss but random inactivation characterize primary biliary cirrhosis. Hepatology 2007, 46:456-462.
61. Ansari A.A., Gershwin M.E. Navigating the passage between Charybdis and Scylla: recognizing the achievements of Noel Rose. J Autoimmun 2009, 33:165-169.
62. Whittingham S., Rowley M.J., Gershwin M.E. A tribute to an outstanding immunologist - Ian Reay Mackay. J Autoimmun 2008, 31:197-200.
63. Gershwin M.E. Bone marrow transplantation, refractory autoimmunity and the contributions of Susumu Ikehara. J Autoimmun 2008, 30:105-107.